Status:
ACTIVE_NOT_RECRUITING
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Humana Healthcare Research, Inc.
Conditions:
Autoimmune Diseases
Rheumatoid Arthritis (RA)
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions i...
Detailed Description
This is a parallel, cluster randomized controlled trial in which medical practices with clinicians who prescribed adalimumab (Humira) to patients in a Humana Medicare Prescription Drug Plan (PDP) will...
Eligibility Criteria
Inclusion
- Wrote 7 or more adalimumab prescriptions that were filled by patients enrolled in research-eligible Humana Medicare Part D plans in the calendar year 2025
Exclusion
- Retired
- Not able to identify active clinical practice in the US (50 states plus Washington DC)
Key Trial Info
Start Date :
November 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
1325 Patients enrolled
Trial Details
Trial ID
NCT07221890
Start Date
November 6 2025
End Date
March 31 2027
Last Update
December 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Humana Healthcare Research, Inc.
Louisville, Kentucky, United States, 40202
2
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115